Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Change in Accured Expenses (2021 - 2025)

Zymeworks' Change in Accured Expenses history spans 5 years, with the latest figure at $1.3 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 81.8% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$23.6 million, a 265.13% decrease, with the full-year FY2025 number at -$23.6 million, down 265.13% from a year prior.
  • Change in Accured Expenses hit $1.3 million in Q4 2025 for Zymeworks, down from $3.3 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for ZYME hit a ceiling of $37.6 million in Q4 2022 and a floor of -$28.3 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged -$1.3 million across 5 years, with a median of $1.7 million in 2022.
  • Biggest five-year swings in Change in Accured Expenses: soared 551.75% in 2022 and later plummeted 1031.47% in 2025.
  • Tracing ZYME's Change in Accured Expenses over 5 years: stood at $5.8 million in 2021, then soared by 551.75% to $37.6 million in 2022, then crashed by 159.42% to -$22.3 million in 2023, then surged by 132.87% to $7.3 million in 2024, then crashed by 81.8% to $1.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for ZYME at $1.3 million in Q4 2025, $3.3 million in Q3 2025, and -$7.1 million in Q2 2025.